CN116209671A - 补体因子c3的抑制剂及其医学用途 - Google Patents
补体因子c3的抑制剂及其医学用途 Download PDFInfo
- Publication number
- CN116209671A CN116209671A CN202180062742.5A CN202180062742A CN116209671A CN 116209671 A CN116209671 A CN 116209671A CN 202180062742 A CN202180062742 A CN 202180062742A CN 116209671 A CN116209671 A CN 116209671A
- Authority
- CN
- China
- Prior art keywords
- complement
- pharmaceutically acceptable
- sar
- solvate
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20186297 | 2020-07-16 | ||
| EP20186297.6 | 2020-07-16 | ||
| PCT/EP2021/069798 WO2022013374A1 (en) | 2020-07-16 | 2021-07-15 | Inhibitors of complement factor c3 and their medical uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116209671A true CN116209671A (zh) | 2023-06-02 |
Family
ID=71661768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180062742.5A Pending CN116209671A (zh) | 2020-07-16 | 2021-07-15 | 补体因子c3的抑制剂及其医学用途 |
Country Status (11)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025001976A1 (zh) * | 2023-06-29 | 2025-01-02 | 刘晓蓉 | 新型补体抑制剂及其制备、应用和产品 |
| WO2026130360A1 (zh) * | 2024-12-20 | 2026-06-25 | 重庆派金生物科技有限公司 | 靶向抑制c3与c5补体的双功能多肽、双功能多肽偶联物及它们的应用 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020017385A2 (pt) | 2018-02-27 | 2020-12-15 | Zp Spv 3 K/S | Análogos de compstatina, métodos e seus usos médicos |
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| EP4622992A1 (en) * | 2022-11-24 | 2025-10-01 | Amyndas Pharmaceuticals US LLC | Compstatin analogs for vector-based therapy |
| CN118812653A (zh) * | 2023-04-18 | 2024-10-22 | 成都奥达生物科技有限公司 | 一种长效坎普他汀化合物 |
| US20260234189A1 (en) | 2025-01-24 | 2026-08-13 | Boehringer Ingelheim International Gmbh | Novel and stable compstatin analogues |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000505068A (ja) | 1996-03-13 | 2000-04-25 | トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア | 補体活性化を阻害する新規ペプチド類 |
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| WO1999013899A1 (en) | 1997-09-17 | 1999-03-25 | Trustees Of The University Of Pennsylvania | Peptides and peptidomimetics for inhibiting complement activation |
| US7989589B2 (en) | 2002-09-20 | 2011-08-02 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved activity |
| CN101325963B (zh) | 2005-10-08 | 2016-01-27 | 博泰迪亚制药公司 | 用于眼部病症的补体抑制素和其类似物 |
| ES2390828T3 (es) | 2005-11-28 | 2012-11-16 | The Trustees Of The University Of Pennsylvania | Análogos potentes de la compstatina |
| WO2008153963A1 (en) | 2007-06-08 | 2008-12-18 | The Trustees Of The University Of Pennsylvania | Structure of compstatin-c3 complex and use for rational drug design |
| CA2813049A1 (en) * | 2010-09-23 | 2012-03-29 | The Trustees Of The University Of Pennsylvania | Modified compstatin with improved stability and binding properties |
| EP2751161B1 (en) * | 2011-08-31 | 2018-09-19 | Huntsmann Advanced Materials Licensing (Switzerland) GmbH | Process for the impregnation of air core reactors, impregnated air core reactor and use of an impregnation system |
| PL2753636T3 (pl) | 2011-09-07 | 2020-05-18 | The Trustees Of The University Of Pennsylvania | Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych |
| WO2014100407A1 (en) | 2012-12-19 | 2014-06-26 | The Regents Of The University Of California | Compstatin analogs |
| US10213476B2 (en) * | 2014-03-17 | 2019-02-26 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved potency and pharmacokinetic properties |
| BR112020017385A2 (pt) * | 2018-02-27 | 2020-12-15 | Zp Spv 3 K/S | Análogos de compstatina, métodos e seus usos médicos |
| ES3049784T3 (en) * | 2019-08-27 | 2025-12-18 | Zp Spv 3 K/S | Compstatin analogues and their medical uses |
-
2021
- 2021-07-15 JP JP2023502703A patent/JP2023538807A/ja active Pending
- 2021-07-15 CA CA3185730A patent/CA3185730A1/en active Pending
- 2021-07-15 WO PCT/EP2021/069798 patent/WO2022013374A1/en not_active Ceased
- 2021-07-15 MX MX2023000679A patent/MX2023000679A/es unknown
- 2021-07-15 US US18/016,490 patent/US20230287051A1/en active Pending
- 2021-07-15 KR KR1020237005557A patent/KR20230039718A/ko not_active Ceased
- 2021-07-15 IL IL299870A patent/IL299870A/en unknown
- 2021-07-15 CN CN202180062742.5A patent/CN116209671A/zh active Pending
- 2021-07-15 EP EP21742144.5A patent/EP4182023A1/en active Pending
- 2021-07-15 AU AU2021309548A patent/AU2021309548A1/en active Pending
-
2023
- 2023-02-09 CO CONC2023/0001411A patent/CO2023001411A2/es unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025001976A1 (zh) * | 2023-06-29 | 2025-01-02 | 刘晓蓉 | 新型补体抑制剂及其制备、应用和产品 |
| WO2026130360A1 (zh) * | 2024-12-20 | 2026-06-25 | 重庆派金生物科技有限公司 | 靶向抑制c3与c5补体的双功能多肽、双功能多肽偶联物及它们的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20230287051A1 (en) | 2023-09-14 |
| CA3185730A1 (en) | 2022-01-20 |
| EP4182023A1 (en) | 2023-05-24 |
| MX2023000679A (es) | 2023-04-18 |
| CO2023001411A2 (es) | 2023-02-16 |
| JP2023538807A (ja) | 2023-09-12 |
| KR20230039718A (ko) | 2023-03-21 |
| WO2022013374A1 (en) | 2022-01-20 |
| AU2021309548A1 (en) | 2023-02-23 |
| IL299870A (en) | 2023-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7170081B2 (ja) | 新規なポリペプチド | |
| CN112041330B (zh) | 坎普他汀类似物及其医学用途 | |
| JP6785932B2 (ja) | 構築されたポリペプチド特異性のモジュレーション | |
| JP2023538807A (ja) | 補体因子c3の阻害剤及びそれらの医学的使用 | |
| JP7711044B2 (ja) | コンプスタチン類似体及びその医学的使用 | |
| JP2020128443A (ja) | インターロイキン23受容体の経口ペプチド阻害剤および炎症性腸疾患を処置するためのそれらの使用 | |
| KR20250166123A (ko) | 신경계 복구를 위한 단백질 티로신 포스파타제 웨지 도메인 펩티드 이량체 | |
| EA051613B1 (ru) | Ингибиторы фактора с3 системы комплемента и варианты их применения в медицине | |
| HK40092906A (en) | Inhibitors of complement factor c3 and their medical uses | |
| EA049126B1 (ru) | Аналоги компстатина и пути их медицинского применения | |
| HK40102364A (en) | Compstatin analogues and their medical uses | |
| HK40102364B (en) | Compstatin analogues and their medical uses | |
| WO2024235270A1 (zh) | 补体抑制剂及其制备方法和用途 | |
| CN120435304A (zh) | Ccr2抑制剂及使用方法 | |
| JP2008509692A (ja) | ペプチドの多量体 | |
| HK1227702A1 (en) | Novel polypeptides | |
| HK1227702B (en) | Novel polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40092906 Country of ref document: HK |